PARACETAMOL, DIPHENHYDRAMINE, INFLIXIMAB, TOCILIZUMAB, AZD7789, EPINEPHRINE
D9571C00001
Phase 2 small_molecule active
Quick answer
PARACETAMOL, DIPHENHYDRAMINE, INFLIXIMAB, TOCILIZUMAB, AZD7789, EPINEPHRINE for Relapsed/Refractory Classical Hodgkin Lymphoma is a Phase 2 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Relapsed/Refractory Classical Hodgkin Lymphoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active